Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

Article Abstract:

HIV patients who are actively abusing drugs are less likely to comply with treatment, according to a study of 764 HIV patients. For this reason, all HIV-infected drug addicts should be offered substance abuse treatments in addition to anti-HIV drugs.

Behavior, Drug addicts, Drug abusers, Drug use

---

Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort

Article Abstract:

A study was conducted to evaluate the incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis (IE) in HIV-infected patients. There is a significant morbidity and 1-year mortality in HIV-infected patients with IE, indicating the need for more aggressive follow-up, especially in those over 40 years of age.

Health aspects, Patient outcomes, Diagnosis, Risk factors, Demographic aspects, Infective endocarditis, Clinical report

---

Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

Article Abstract:

Use of highly active antiretroviral therapy (HAART) with patients visiting clinics is much less successful in suppressing HIV-1 RNA virus counts than it is with patients in controlled clinical trials. the major factor contributing to this failure is patients missing clinic visits. Among 273 patients taking a protease inhibitor regimen for the first time, successful suppression of the viral load reached a high of 44% of patients at three to seven months into the study, then dropped off to 37% after seven to 14 months. This is compared to clinical trials in which HAART reduces levels 60% to 90% of patients.

Statistical Data Included, Evaluation, Ambulatory care facilities, Prognosis, Clinical trials, Medical care utilization, Clinics, Highly active antiretroviral therapy

Similar abstracts:

• Abstracts: Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Genetic analysis of HIV-1 samples from Spain
• Abstracts: Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response
• Abstracts: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States
• Abstracts: Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study.
• Abstracts: Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.